- Easy Tracking In The Watchlist
High volatility in Processa Pharmaceuticals Inc. stock price on Friday which ended trading at $2.15
(Updated on Jul 31, 2026)
The Processa Pharmaceuticals Inc. stock price gained 5.39% on the last trading day (Friday, 31st Jul 2026), rising from $2.04 to $2.15. During the last trading day the stock fluctuated 11.98% from a day low at $1.92 to a day high of $2.15. The price has risen in 6 of the last 10 days but is still down by -6.93% for this period. Volume fell on the last day by -56 thousand shares and in total, 394 thousand shares were bought and sold for approximately $847.37 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -15.94% during the next 3 months and, with a 90% probability hold a price between $1.37 and $2.54 at the end of this 3-month period.
PCSA Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 5.91%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Processa Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $2.48 and $2.19. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Support, Risk & Stop-loss for Processa Pharmaceuticals Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $2.04 and $2.03. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Processa Pharmaceuticals Inc. finds support just below today's level at $2.04. If this is broken, then the next support from accumulated volume will be at $2.03 and $1.98.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.230 between high and low, or 11.98%. For the last week the stock has had daily average volatility of 16.89%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (PCSA) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect Processa Pharmaceuticals Inc. to open at $2.07, and during the day (based on 14 day Average True Range), to move between $1.99 and $2.31, which gives a possible trading interval of +/-$0.313 (+/-15.70%) up or down from last closing price. If Processa Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 15.70% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.16 (0.47%) than the support at $2.04 (5.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
Processa Pharmaceuticals Inc. will release earnings BMO on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is -$1.00. We will update the financials statements for Processa Pharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 11.93% in the first trading day after earnings release.
Is Processa Pharmaceuticals Inc. stock A Buy?
Processa Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-1.292
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $2.07 ( 3.57%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
PCSA Performance
Trading levels for PCSA
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.30 | 7.13% |
| R2 | 2.22 | 3.05% |
| R1 | 2.16 | 0.521% |
| Price | 2.15 | |
| S1 | 1.99 | -7.65% |
| S2 | 1.93 | -10.18% |
| S3 | 1.84 | -14.26% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 2.37 | 10.23% |
| R2 | 2.24 | 4.19% |
| R1 | 2.16 | 0.465% |
| Price | 2.15 | |
| S1 | 2.04 | -5.12% |
| S2 | 2.03 | -5.58% |
| S3 | 1.98 | -7.91% |
FAQ
Click here for our free guide on how to buy Processa Pharmaceuticals Inc. Stock.
Buy PCSA